A Study Based on Health Insurance Data About the Treatment of Patients Who Have Been Newly Diagnosed With Chronic Obstructive Pulmonary Disease (COPD)

CompletedOBSERVATIONAL
Enrollment

17,464

Participants

Timeline

Start Date

November 20, 2019

Primary Completion Date

July 1, 2020

Study Completion Date

July 1, 2020

Conditions
Pulmonary Disease, Chronic Obstructive
Trial Locations (1)

23966

Institute for pharmacoeconomics and pharmaceutical logistics e.V (IPAM), Wismar

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04097223 - A Study Based on Health Insurance Data About the Treatment of Patients Who Have Been Newly Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter